2446. Deputy Sorca Clarke asked the Minister for Health her views on the continued use of pharmaceutical products manufactured by Israeli companies within the HSE, in light of calls from CHI consultants to end the use of Israeli drugs; and if she will make a statement on the matter. [46140/25]
Topics / Medicinal Products
A subject heading for parliamentary questionsMedicinal Products
1,233 questions from 132 TDs, between 22 January 2025 and 22 October 2026.
1,233
questions
1,229 written, 4 oral
132
TDs have asked
11
parties and groups
Independents counted together
4
departments asked
Questions per month
The record holds no questions for August, when the Dáil does not sit.
Jan 2025Oct 2026
Show as a table
| Month | Questions |
|---|---|
| January 2025 | 17 |
| February 2025 | 66 |
| March 2025 | 28 |
| April 2025 | 35 |
| May 2025 | 43 |
| June 2025 | 58 |
| July 2025 | 56 |
| August 2025 | 0 |
| September 2025 | 36 |
| October 2025 | 38 |
| November 2025 | 58 |
| December 2025 | 27 |
| January 2026 | 18 |
| February 2026 | 70 |
| March 2026 | 142 |
| April 2026 | 87 |
| May 2026 | 156 |
| June 2026 | 127 |
| July 2026 | 82 |
| August 2026 | 0 |
| September 2026 | 62 |
| October 2026 | 27 |
Who asks, by party
The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.
The TDs who asked most
Members of the Government answer questions rather than ask them. Each question counts once.
-
196
-
75
-
43
-
42
-
39
-
26
-
26
-
26
Asked of
Debated under the same heading
Debates whose official heading is exactly these words.
The questions
2618. Deputy Cormac Devlin asked the Minister for Health if she will provide an update on the NCPE appraisal of ritlecitinib (litfulo) for severe alopecia areata, including current stage, any ongoing HSE pricing and reimbursement engagement with the applicant; the expected timelines for a decision and proposed prescribing setting if approved; and if she will make a statement on the matter. [46999/25]
2619. Deputy Cormac Devlin asked the Minister for Health if an application has been received by the HSE for pricing and reimbursement of baricitinib for the alopecia areata indication; if not, if the HSE or her Department has engaged with the marketing authorisation holder regarding a submission; and if she will make a statement on the matter. [47000/25]
2620. Deputy Cormac Devlin asked the Minister for Health if her Department, the HSE or the HPRA has engaged with the manufacturer of deuruxolitinib (leqselvi) regarding plans for EU submission and availability in Ireland; if any named-patient or compassionate access requests have been received; and if she will make a statement on the matter. [47001/25]
2646. Deputy Cormac Devlin asked the Minister for Health the current days of cover for the top 100 essential medicines, by category; the medicines experiencing repeated shortages since 2023; the plan to establish a rotating national reserve and domestic fill finish capacity; and if she will make a statement on the matter. [47208/25]
2551. Deputy Darren O'Rourke asked the Minister for Health for an update on the assessment, funding and use, including early use through an early access scheme, of givinostat for muscular dystrophy patients; and if she will make a statement on the matter. [40811/25]
2573. Deputy Paula Butterly asked the Minister for Health to respond to correspondence (details supplied) regarding treatments for adults living with spinal muscular atrophy in Ireland; and if she will make a statement on the matter. [40959/25]
2575. Deputy Aengus Ó Snodaigh asked the Minister for Health the steps being taken to address the growing concern re the shortage of salbutamol. [40971/25]
2584. Deputy Barry Ward asked the Minister for Health further to Parliamentary Question No. 904 of 15 July 2025, if she will engage with a union (details supplied) to encourage the use of European-made medications wherever possible; and if she will make a statement on the matter. [40998/25]
2602. Deputy David Cullinane asked the Minister for Health if she has engaged with her counterpart in the North to explore the potential for maximising access to new medicines while ensuring value for money through joint arrangements, such as for gavinostat for which there is a pricing arrangement in the North, but not in this State, but a lack of capacity to issue the treatment; and if she will make a statement on t…
2649. Deputy Barry Heneghan asked the Minister for Health the plans in place for the assessment and potential inclusion of the psychiatric medication lumateperone for the treatment of bipolar disorder under the drug payment scheme; and if she will make a statement on the matter. [41240/25]
2678. Deputy Ciarán Ahern asked the Minister for Health if she is aware of the growing use of HHC (hexahydrocannabinol) vapes, a synthetic cannabinoid product, among young people; if the new Public Health (Nicotine Inhaling Products) Bill 2025 will contain provisions to curtail this trend; and if not, if she will produce separate legislation on the matter; and if she will make a statement on the matter. [41325/25]
2679. Deputy Pádraig Rice asked the Minister for Health if the Medicines Management Programme’s proposed reclassification of high protein (HP) oral nutrition supplements to list B will be suspended to allow the scientific data to be properly evaluated; if she is aware of thejoint position statement detailing the clinical, ethical, and economic concerns associated with this proposal endorsed by over500 healthcare prof…
2680. Deputy Pádraig Rice asked the Minister for Health if she will request that the Medicines Management Programme begins formal engagement with the Irish Society for Clinical Nutrition and Metabolism, the Irish Nutrition and Dietetic Institute and academic nutrition leaders to revise guidance on high-protein (HP) ONS products in line with international expert consensus; and if she will make a statement on the matte…
2726. Deputy Robert Troy asked the Minister for Health the reason the new mandibular device used to treat sleep apnoea is not approved under the drugs payment scheme (details supplied); and whether the new device will be included under the scheme as soon as possible. [41715/25]
2791. Deputy Ken O'Flynn asked the Minister for Health if she will consider reviewing the current regulatory status of melatonin in Ireland, given that it is available over the counter in many EU countries. [41999/25]
2792. Deputy Ken O'Flynn asked the Minister for Health if she will outline the rationale for maintaining prescription-only of melatonin access in this jurisdiction. [42000/25]
2793. Deputy Ken O'Flynn asked the Minister for Health if she will address the significant cost disparity between Irish pharmacy-dispensed melatonin and equivalent products available legally from EU-based manufacturers. [42001/25]
2794. Deputy Ken O'Flynn asked the Minister for Health 1792 the measures, if any, being considered to ensure price transparency, and to protect patients, particularly those with long-term conditions, from excessive mark-ups for essential medications that are not currently covered under public schemes such as the drug payment scheme or the medical card system. [42002/25]
2795. Deputy Aengus Ó Snodaigh asked the Minister for Health the reason octenisan is not included on the general medical scheme for those with medical cards and for whom this product is prescribed. [42003/25]
2882. Deputy Pádraig Rice asked the Minister for Health if her attention has been brought to the exclusion of transgender women from the free HRT scheme (details supplied); if she will re-examine the guidance issued to pharmacies to ensure that transgender women are not excluded from the scheme; and if she will make a statement on the matter. [42566/25]
3019. Deputy Ken O'Flynn asked the Minister for Health if the case of an elderly person (details supplied) will be reviewed who was recently removed from the public health nurse service, which had been providing essential vitamin B12 injections on a three-week cycle. [42857/25]
3023. Deputy Conor Sheehan asked the Minister for Health the action she proposes to take to deal with the unregulated operators in the cosmetics industry; and if she will make a statement on the matter. [42870/25]
3024. Deputy Conor Sheehan asked the Minister for Health if she intends to introduce licensing for non-surgical cosmetic procedures; the form that licensing would take; and if she will make a statement on the matter. [42871/25]
3025. Deputy Conor Sheehan asked the Minister for Health for an update on The Patient Safety (Licensing) Bill 2017, including when the legislation will be referred back to her from the Attorney General’s office; a timeline for enactment; and if she will make a statement on the matter. [42872/25]